|
|
| | Z-Phe-His-Leu-OH Basic information |
| Product Name: | Z-Phe-His-Leu-OH | | Synonyms: | Z-FHL-OH;N-ALPHA-CBZ-PHE-HIS-LEU;Z-L-PHENYLALANYL-L-HISTIDYL-L-LEUCINE;L-Leucine, N-[(phenylmethoxy)carbonyl]-L-phenylalanyl-L-histidyl-;N-(Benzyloxycarbonyl)-L-phenylalanyl-L-histidyl-L-leucine;CBZ-Phe-His-Leu-OH;{Cbz}-Phe-His-Leu;Z-Phe-His-Leu | | CAS: | 28458-19-7 | | MF: | C29H35N5O6 | | MW: | 549.62 | | EINECS: | | | Product Categories: | | | Mol File: | 28458-19-7.mol |  |
| | Z-Phe-His-Leu-OH Chemical Properties |
| storage temp. | -15°C | | Sequence | {Cbz}-Phe-His-Leu |
| | Z-Phe-His-Leu-OH Usage And Synthesis |
| Uses | Z-Phe-His-Leu is the substrate of plasma converting enzyme, with enhanced discriminating power at peak converting enzyme inhibition[1]. | | References | [1] Juillerat L, et al. Determinants of angiotensin II generation during converting enzyme inhibition[J]. Hypertension, 1990, 16(5): 564-572. |
| | Z-Phe-His-Leu-OH Preparation Products And Raw materials |
|